Sean Dickson studies the underlying drivers of rising drug costs and identifies policy options that limit spending growth as part of Pew’s drug spending research initiative. His research considers the role of government regulations and incentives on pharmaceutical markets, highlighting ways public and private payers can manage their drug spending.
Dickson joined Pew after working for both pharmaceutical manufacturers and state governments on issues related to drug pricing, development, and access. During his time in the pharmaceutical industry, Dickson counseled manufacturers on compliance with federal drug price reporting requirements. He subsequently supported state public health departments in discount negotiations with drug manufacturers and advising on compliance with federal drug discount program requirements.
Dickson holds a bachelor’s degree in public policy from the University of Chicago and a master’s in public health and a law degree from the University of Michigan.